- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03435549
Automated Hovering for Joint Replacement Surgery
July 18, 2019 updated by: University of Pennsylvania
This will evaluate the effectiveness of automated hovering to encourage patients to be discharged to home after hip or knee replacement surgery.
Automated hovering includes monitoring of physical activity with an activity monitor, tracking of pain scores, daily feedback and motivational messages, social influence, and connection to clinicians as needed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to test the approach of automated hovering to encourage patients to be discharged to home safely after lower extremity joint replacement surgery (LEJR).
The investigators will target those patients undergoing hip or knee replacement surgery at a large urban hospital system at two different sites.
The investigators aim is to increase the number of patients that are discharged to home, by providing patients with a physical activity pedometer, daily pain score tracking through bi-directional text messaging, milestone and nudge messaging for recovery, social influence, and connection to clinicians as needed for 6 weeks after surgery.
Eligible participants are age 18-85, with a Risk Assessment and Prediction Tool (RAPT) score of 6-8 and are scheduled to undergo lower-extremity joint replacement surgery.
Participants will be randomized 1:1 to usual care (Arm 1) and intervention (Arms 2a and 2b).
After enrollment with the monitoring device, participants in the intervention group will be randomized 1:1 to Arm 2a (remote monitoring) or Arm 2b (remote monitoring + goal-setting and social support).
Both intervention arms will receive the intervention for 6 weeks post-surgery.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eligibility Criteria: University of Pennsylvania Health System (UPHS) patients between the ages of 18-85 with a Risk Assessment and Prediction Tool (RAPT) of 6-8 and scheduled to undergo primary lower-extremity joint replacement surgery.
Exclusion Criteria:
- Patients will be excluded if they do not meet all of the inclusion criteria, or if they have bilateral or revision surgery, dementia, end stage renal disease, cirrhosis, metastatic cancer, non- English speaker, or other physical impairment (ex. amputation)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Arm 1: Control Arm (Usual care)
If Patient is randomized to Arm 1, no contact will occur, patient will receive standard and routine clinical care
|
|
Experimental: Arm 2a: Remote monitoring
If Patient is randomized to Arm 2a they will remote monitoring for 6 weeks post-surgery
|
Patients given an activity tracker to wear for 6 weeks after LEJR replacement surgery.
For 2 weeks after surgery, they will also receive a daily text messages asking what their pain is on a scale of 0 to 10.
They will be asked to reply to the text with their pain score.
They will also be sent occasional messaging about their recovery, tips of what to do, and feedback on their progress.
They will also also be sent a text message if they stop using their activity tracker for 3 days.
|
Experimental: Arm 2b: Remote monitoring plus goal setting and social support
If Patient is randomized to Arm 2b, they will receive a remote monitoring plus social support and nudge messaging for 6 weeks post-surgery
|
Patients given activity tracker to wear for 6 weeks after LEJR surgery.
For 2 weeks after surgery, they will receive a daily text messages asking what their pain is on a scale of 0 to 10 and asked to reply by text.
They will be sent occasional messaging about their recovery, tips of what to do, and feedback on their progress.
They will also also be sent a text message if they stop using their activity tracker for 3 days.
Patients will be asked to identify a a friend or family member to act as support partner.
The study will share progress updates with support partner and contact this individual if patient stops wearing the activity tracker for over 3 days.
This partner will also be able to provide supportive messages to help encourage them to reach their activity goals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Discharged to home
Time Frame: Day of discharge through study completion at 6 weeks
|
% of patients discharged to home
|
Day of discharge through study completion at 6 weeks
|
Step increase
Time Frame: 6 weeks post discharge
|
% of step increase as measured by activity tracker
|
6 weeks post discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Days spent at home
Time Frame: 6 weeks post discharge
|
Number of days spent at home after discharge
|
6 weeks post discharge
|
Timed Up and Go (TUG) score
Time Frame: 6 weeks post discharge
|
% change in TUG score
|
6 weeks post discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 7, 2018
Primary Completion (Actual)
April 12, 2019
Study Completion (Actual)
April 12, 2019
Study Registration Dates
First Submitted
February 9, 2018
First Submitted That Met QC Criteria
February 14, 2018
First Posted (Actual)
February 19, 2018
Study Record Updates
Last Update Posted (Actual)
July 22, 2019
Last Update Submitted That Met QC Criteria
July 18, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 828882
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Joint Disease
-
University of Alberta, Graduate Orthodontic ProgramUniversity of AlbertaCompletedTemporomandibular Degenerative Joint DiseaseCanada
-
DePuy InternationalActive, not recruitingNoninflammatory Degenerative Joint DiseaseUnited States, Hong Kong, Malaysia, United Kingdom, Australia, Austria, Belgium, Canada, Germany, New Zealand, Singapore, Switzerland, Korea, Republic of
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
Anderson Orthopaedic Research InstituteDePuy Orthopaedics; University of Western Ontario, CanadaCompletedNon-inflammatory Degenerative Joint DiseaseUnited States, Canada
-
Smith & Nephew Pte LtdActive, not recruitingNon-inflammatory Degenerative Joint DiseaseIndia, Korea, Republic of, Italy, South Africa
-
Stryker South PacificTerminatedNon-inflammatory Degenerative Joint DiseaseAustralia
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseNetherlands
-
Biomimedica, IncTerminatedDegenerative Joint Disease of the HipNetherlands
-
Smith & Nephew Orthopaedics AGIqvia Pty Ltd; eResearchTechnology, Inc; M Squared Associates,Inc.; ExecuPharm...CompletedDegenerative Joint Disease of HipBelgium, Finland, Spain, United Kingdom
Clinical Trials on Remote monitoring
-
University of PennsylvaniaCompletedHypertensionUnited States
-
Abbott Medical DevicesCompletedCongestive Heart Failure TreatedItaly
-
Biotronik FranceBiotronik SE & Co. KGCompletedBradycardia | Pacemaker, ArtificialFrance
-
Abbott Medical DevicesWithdrawnHeart Failure | Cardiovascular Disease | Arrhythmias, Cardiac | Heart DiseaseUnited States
-
Abbott Medical DevicesCompleted
-
Federico II UniversityRecruitingHeart Failure | Sudden Cardiac Death | Cardiac ArrhythmiasItaly
-
Mayo ClinicCompleted
-
Northwestern UniversityOmron Healthcare Co., Ltd.Completed
-
Semmelweis University Heart and Vascular CenterRecruiting
-
University of Colorado, DenverMallinckrodtRecruitingInfantile Spasms, Non-IntractableUnited States